Callio Therapeutics
Seattle, WA
Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.
calliotx.comCompany Details
Founded
- 2025
Employees
- Between 5 - 20 employees
Raised
- $187,000,000
Headquarters Location
- Seattle, WA
Public
- No
Acquired
- No
CEO
Piers Ingram
Founders
- Piers IngramJerome Boyd-Kirkup
Company Collections
These are collections Callio Therapeutics is a part of. Click on the collection name to view similar companies.
Callio Therapeutics Headquarters Location
Seattle, WA 98103
Total Amount Raised: $187,000,000
Callio Therapeutics Funding Rounds
Series A
$187,000,000
Funding info provided by Diffbot.
Callio Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Callio Therapeutics.